Newswise News from ISPOR—The Professional Society for Health Economics and Outcomes Research display Latest news from ISPOR—The Professional Society for Health Economics and Outcomes Research on Newswise en-us Copyright 2024 Newswise Newswise News from ISPOR—The Professional Society for Health Economics and Outcomes Research 115 31 / /images/newswise-logo-rss.gif ISPOR Announces New Strategic Plan 2030 /articles/ispor-announces-new-strategic-plan-2030/?sc=rsin /articles/ispor-announces-new-strategic-plan-2030/?sc=rsin Mon, 29 Jul 2024 04:05:52 EST ISPOR--The Professional Society for Health Economics and Outcomes Research announced its new Strategic Plan 2030 that presents a bold new vision for the Society and the field of health economics and outcomes research (HEOR). ISPOR--The Professional Society for Health Economics and Outcomes Research Measuring What Matters: Broadening the Scope of Health Economics Evaluation to Incorporate Well-Being /articles/measuring-what-matters-broadening-the-scope-of-health-economics-evaluation-to-incorporate-well-being/?sc=rsin /articles/measuring-what-matters-broadening-the-scope-of-health-economics-evaluation-to-incorporate-well-being/?sc=rsin Tue, 09 Jul 2024 04:05:01 EST ISPOR--The Professional Society for Health Economics and Outcomes Research announced the publication of a special themed section of research papers in Value in Health that offer insights into facets of economic evaluation aimed to incorporate well-being into decision making. ISPOR--The Professional Society for Health Economics and Outcomes Research Confronting the Backlash Against QALYs: Key Insights From Leading Health Economists /articles/confronting-the-backlash-against-qalys-key-insights-from-leading-health-economists/?sc=rsin /articles/confronting-the-backlash-against-qalys-key-insights-from-leading-health-economists/?sc=rsin Tue, 18 Jun 2024 04:05:13 EST ISPOR announced the publication of a collection of papers that examine the long-standing debate surrounding the use of quality-adjusted life years (QALYs) and alternative measures in healthcare decision making. ISPOR--The Professional Society for Health Economics and Outcomes Research ISPOR Good Practices Report Offers Guidance for Using Real-World Data From EHRs in Health Technology Assessments /articles/ispor-good-practices-report-offers-guidance-for-using-real-world-data-from-ehrs-in-health-technology-assessments/?sc=rsin /articles/ispor-good-practices-report-offers-guidance-for-using-real-world-data-from-ehrs-in-health-technology-assessments/?sc=rsin Mon, 17 Jun 2024 04:05:59 EST ISPOR--The Professional Society for Health Economics and Outcomes Research announced today the publication of an ISPOR Good Practices Report that proposes a framework for assessing the suitability of electronic health records data for use in health technology assessments. The report, "Assessing Real-World Data from Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist: A Good Practices Report of an ISPOR Task Force" was published in the June 2024 issue of Value in Health. ISPOR--The Professional Society for Health Economics and Outcomes Research ISPOR Announces 2024-2025 Board of Directors /articles/ispor-announces-2024-2025-board-of-directors/?sc=rsin /articles/ispor-announces-2024-2025-board-of-directors/?sc=rsin Tue, 28 May 2024 04:05:14 EST ISPOR--The Professional Society for Health Economics and Outcomes Research announced the results of its recent elections. The Society's membership selected its new president-elect and 4 new board members. ISPOR--The Professional Society for Health Economics and Outcomes Research When and How to Conduct Health Technology Assessments for Biosimilars? /articles/when-and-how-to-conduct-health-technology-assessments-for-biosimilars/?sc=rsin /articles/when-and-how-to-conduct-health-technology-assessments-for-biosimilars/?sc=rsin Mon, 13 May 2024 04:05:36 EST ISPOR announced the publication of a report from the ISPOR Biosimilars Special Interest Group highlighting the need for clearer guidance on when and how to conduct health technology assessments (HTAs) for biosimilars. ISPOR--The Professional Society for Health Economics and Outcomes Research ISPOR Announces Patient-Centered Research Summit 2024 /articles/ispor-announces-patient-centered-research-summit-2024/?sc=rsin /articles/ispor-announces-patient-centered-research-summit-2024/?sc=rsin Mon, 22 Apr 2024 09:05:14 EST ISPOR--The Professional Society for Health Economics and Outcomes Research announced the sessions and speakers for its Patient-Centered Research Summit 2024. The Summit is scheduled to be held May 5 in Atlanta, GA, USA and is co-located with the Society's annual international conference, ISPOR 2024. ISPOR--The Professional Society for Health Economics and Outcomes Research ISPOR 2024 Plenaries and Speakers Announced /articles/ispor-2024-plenaries-and-speakers-announced/?sc=rsin /articles/ispor-2024-plenaries-and-speakers-announced/?sc=rsin Mon, 22 Apr 2024 04:05:07 EST ISPOR announced the plenary sessions and speakers for ISPOR 2024, its annual international conference., and the leading global conference for health economics and outcomes research (HEOR). ISPOR 2024 will be held May 5-8 in Atlanta, GA, USA. ISPOR--The Professional Society for Health Economics and Outcomes Research ISPOR Global Panel Proposes New Structure to Improve Definitions of Digital Health Interventions /articles/ispor-global-panel-proposes-new-structure-to-improve-definitions-of-digital-health-interventions/?sc=rsin /articles/ispor-global-panel-proposes-new-structure-to-improve-definitions-of-digital-health-interventions/?sc=rsin Tue, 09 Apr 2024 04:05:02 EST ISPOR--The Professional Society for Health Economics and Outcomes Research announced the publication of a report from the ISPOR Digital Health Special Interest Group that proposes a new framework to help standardize and clarify definitions used for digital health interventions. ISPOR--The Professional Society for Health Economics and Outcomes Research ISPOR Launches HEOR by Topic Microsite /articles/ispor-launches-heor-by-topic-microsite/?sc=rsin /articles/ispor-launches-heor-by-topic-microsite/?sc=rsin Tue, 02 Apr 2024 04:05:41 EST ISPOR--The Professional Society for Health Economics and Outcomes Research (HEOR) announced today that it has launched a new microsite that provides HEOR information and resources organized by topical areas of interest--HEOR by Topic. ISPOR--The Professional Society for Health Economics and Outcomes Research ISPOR International Panel Calls for Consensus on Medication Adherence Measures /articles/ispor-international-panel-calls-for-consensus-on-medication-adherence-measures/?sc=rsin /articles/ispor-international-panel-calls-for-consensus-on-medication-adherence-measures/?sc=rsin Mon, 26 Feb 2024 04:05:47 EST ISPOR--The Professional Society for Health Economics and Outcomes Research announced the publication of a new report from the ISPOR Medication Adherence and Persistence Special Interest Group revealing significant inconsistencies in how researchers measure the effectiveness of interventions aimed at improving medication adherence. The report, "A Systematic Review of Outcomes for Assessment of Medication Adherence Enhancing Interventions: An ISPOR Special Interest Group Report" was published in the February 2024 issue of Value in Health. ISPOR--The Professional Society for Health Economics and Outcomes Research ISPOR Launches New HEOR Learning Platform /articles/ispor-launches-new-heor-learning-platform/?sc=rsin /articles/ispor-launches-new-heor-learning-platform/?sc=rsin Mon, 29 Jan 2024 04:05:29 EST ISPOR--The Professional Society for Health Economics and Outcomes Research (HEOR) announced today that it has launched its new online learning platform for HEOR education and training--ISPOR Education Center. ISPOR--The Professional Society for Health Economics and Outcomes Research Value in Health Regional Issues Expands Editorial Scope and Reveals Plans to Transition to Gold Open Access Model /articles/value-in-health-regional-issues-expands-editorial-scope-and-reveals-plans-to-transition-to-gold-open-access-model/?sc=rsin /articles/value-in-health-regional-issues-expands-editorial-scope-and-reveals-plans-to-transition-to-gold-open-access-model/?sc=rsin Tue, 23 Jan 2024 04:05:58 EST Value in Health Regional Issues, an official journal of ISPOR--The Professional Society for Health Economics and Outcomes Research, announced the expansion of its editorial scope and its plan to transition to a gold open access journal. ISPOR--The Professional Society for Health Economics and Outcomes Research Empowering Change: Transforming Health Systems in Low- and Middle-Income Countries /articles/empowering-change-transforming-health-systems-in-low-and-middle-income-countries/?sc=rsin /articles/empowering-change-transforming-health-systems-in-low-and-middle-income-countries/?sc=rsin Mon, 22 Jan 2024 04:05:28 EST ISPOR--The Professional Society for Health Economics and Outcomes Research announced the publication of a special themed section of research papers in Value in Health Regional Issues that highlight innovative approaches to improving health outcomes in low- and middle-income countries. ISPOR--The Professional Society for Health Economics and Outcomes Research ISPOR Publishes New Top 10 HEOR Trends Report /articles/ispor-publishes-new-top-10-heor-trends-report/?sc=rsin /articles/ispor-publishes-new-top-10-heor-trends-report/?sc=rsin Tue, 16 Jan 2024 04:05:40 EST ISPOR--The Professional Society for Health Economics and Outcomes Research (HEOR) announced today the publication of its "2024-2025 Top 10 HEOR Trends Report." ISPOR--The Professional Society for Health Economics and Outcomes Research ISPOR Announces New Editor-in-Chief for Value in Health, Nancy J. Devlin, PhD /articles/ispor-announces-new-editor-in-chief-for-value-in-health-nancy-j-devlin-phd/?sc=rsin /articles/ispor-announces-new-editor-in-chief-for-value-in-health-nancy-j-devlin-phd/?sc=rsin Mon, 18 Dec 2023 04:05:09 EST ISPOR--The Professional Society for Health Economics and Outcomes Research announced today the appointment of Nancy J. Devlin, PhD, University of Melbourne, Australia as an editor-in-chief for Value in Health. ISPOR--The Professional Society for Health Economics and Outcomes Research Mitch Higashi, PhD Joins ISPOR as Associate Chief Science Officer /articles/mitch-higashi-phd-joins-ispor-as-associate-chief-science-officer/?sc=rsin /articles/mitch-higashi-phd-joins-ispor-as-associate-chief-science-officer/?sc=rsin Mon, 11 Dec 2023 04:05:05 EST ISPOR--The Professional Society for Health Economics and Outcomes Research announced that Mitch Higashi, PhD has joined the Society's leadership team as Associate Chief Science Officer. ISPOR--The Professional Society for Health Economics and Outcomes Research Global Experts Highlight Concerns With Implementation of IRA-Mandated Medicare Drug Price Negotiation Program /articles/global-experts-highlight-concerns-with-implementation-of-ira-mandated-medicare-drug-price-negotiation-program/?sc=rsin /articles/global-experts-highlight-concerns-with-implementation-of-ira-mandated-medicare-drug-price-negotiation-program/?sc=rsin Tue, 05 Dec 2023 04:05:15 EST Value in Health announced the publication of 2 new commentaries by leading HEOR experts, both of which raise important questions as the Centers for Medicare & Medicaid Services move forward to implement the Inflation Reduction Act's Medicare Drug Price Negotiation Program. ISPOR--The Professional Society for Health Economics and Outcomes Research Medicare Could Save an Additional $10 Billion Annually Across 10 Drugs by Using a Therapeutic Reference Pricing Approach in Upcoming Price Negotiations /articles/medicare-could-save-an-additional-10-billion-annually-across-10-drugs-by-using-a-therapeutic-reference-pricing-approach-in-upcoming-price-negotiations/?sc=rsin /articles/medicare-could-save-an-additional-10-billion-annually-across-10-drugs-by-using-a-therapeutic-reference-pricing-approach-in-upcoming-price-negotiations/?sc=rsin Tue, 07 Nov 2023 04:05:52 EST Value in Health announced the publication of a study showing that United States Medicare could save up to an additional $5-$10 billion dollars annually across 10 drugs if it negotiated prices using a therapeutic reference pricing approach rather than using the statutory ceiling price alone. ISPOR--The Professional Society for Health Economics and Outcomes Research Global Medical Device Panel Finds Little Evidence Linking Health Technology Assessment Processes to Medical Device Purchasing Decisions /articles/global-medical-device-panel-finds-little-evidence-linking-health-technology-assessment-processes-to-medical-device-purchasing-decisions/?sc=rsin /articles/global-medical-device-panel-finds-little-evidence-linking-health-technology-assessment-processes-to-medical-device-purchasing-decisions/?sc=rsin Mon, 06 Nov 2023 04:05:36 EST Value in Health, the official journal of ISPOR, announced the publication of a systematic literature review showing that there is sparce evidence in the health research literature to link health technology assessment processes and outcomes with device purchasing decisions. ISPOR--The Professional Society for Health Economics and Outcomes Research